(R)-2-((tert-Butoxycarbonyl)amino)pentanedioic acid, 95.0%, 500g

6-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 98%, 250mg

2,6-Dichloro-pyridine-3-sulfonic acid amide, 95.0%, 1g

5-Cyclopropylpyridin-2-ol, 95.0%, 1g

2-ETHYL-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE, 95.0%, 100mg

2-Methyl-6-nitrobenzene-1-sulfonyl chloride, 97%, 1g

tert-Butyl (S)-(4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate, 97%, 100mg

(2R,3R,4S,5R)-6-Oxohexane-1,2,3,4,5-pentayl pentaacetate, 95.0%, 500g

3-Hydroxy-4-methylbenzoesäure, min. 98 %, zur Synthese, 5 g, kunststoffverpackung.

1-methyl-3-((methylamino)methyl)quinolin-2(1H)-one hydrochloride, 95.0%, 250mg

1-Bromopinacolone, 95.0%, 1g

9-(4-Bromophenyl)-9H-carbazole, 95.0%, 1g

tert-butyl 4-(piperidin-3-ylmethyl)piperazine-1-carboxylate, 97.0%, 1g